Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dong Won Baek, Jung Min Lee, Juhyung Kim, Hee Jeong Cho, Joon Ho Moon & Sang Kyun Sohn. (2021) Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia. Expert Review of Hematology 14:8, pages 765-775.
Read now
Read now
Daria Gaut & Monica Mead. (2021) Measurable residual disease in hematopoietic stem cell transplantation-eligible patients with acute myeloid leukemia: clinical significance and promising therapeutic strategies. Leukemia & Lymphoma 62:1, pages 8-31.
Read now
Read now
Articles from other publishers (22)
Michele Malagola, Nicola Polverelli, Alessandra Beghin, Federica Bolda, Marta Comini, Mirko Farina, Enrico Morello, Vera Radici, Eugenia Accorsi Buttini, Simona Bernardi, Federica Re, Alessandro Leoni, Davide Bonometti, Duilio Brugnoni, Arnalda Lanfranchi & Domenico Russo. (2023) Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Frontiers in Oncology 13.
Crossref
Crossref
Cristina Tecchio, Anna Russignan & Mauro Krampera. (2023) Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Frontiers in Oncology 13.
Crossref
Crossref
Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, Ulrike Fritzsche-Friedland, Petra Freiberger, Francis Ayuk, Christine Wolschke, Ulrike Bacher & Nicolaus Kröger. (2022) Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission. Transplantation and Cellular Therapy 28:7, pages 374.e1-374.e9.
Crossref
Crossref
Le-Qing Cao, Yang Zhou, Yan-Rong Liu, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Fei-Fei Tang, Xiao-Dong Mo, Kai-Yan Liu, Qiao-Zhen Fan, Ying-Jun Chang & Xiao-Jun Huang. (2021) A risk score system for stratifying the risk of relapse in B cell acute lymphocytic leukemia patients after allogenic stem cell transplantation. Chinese Medical Journal 134:10, pages 1199-1208.
Crossref
Crossref
Jean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, Pierre-Yves Dumas, Audrey Bidet, Thibaut Leguay, François Vergez, Arnaud Pigneux & Marie C. Béné. (2021) Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia. Cancers 13:4, pages 629.
Crossref
Crossref
Ahmad I. Antar, Zaher K. Otrock, Iman Abou Dalle, Jean El-Cheikh & Ali Bazarbachi. (2020) Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Oncology 10.
Crossref
Crossref
Anne Bouvier, Jérémie Riou, Sylvain Thépot, Aurélien Sutra Del Galy, Sylvie François, Aline Schmidt, Corentin Orvain, Marie-Hélène Estienne, Alban Villate, Damien Luque Paz, Laurane Cottin, Bénédicte Ribourtout, Annaëlle Beucher, Yves Delneste, Norbert Ifrah, Valérie Ugo, Mathilde Hunault-Berger & Odile Blanchet. (2019) Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation. Leukemia 34:5, pages 1342-1353.
Crossref
Crossref
Shyam K. Poudel, Marcos de Lima & Leland Metheny. (2019) Posttransplant maintenance therapy for acute leukemias. Current Opinion in Hematology 26:2, pages 96-111.
Crossref
Crossref
Christina Rautenberg, Ulrich Germing, Rainer Haas, Guido Kobbe & Thomas Schroeder. (2019) Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment. International Journal of Molecular Sciences 20:1, pages 228.
Crossref
Crossref
Valérie Dubois, Mehdi Alizadeh, Jean Henri Bourhis, Pascaline Etancelin, Olivier Farchi, Christophe Ferrand, Laure Goursaud, Isabelle Mollet, Virginie Renac, Pauline Varlet, Ibrahim Yakoub-Agha & Jacques-Olivier Bay. (2017) Étude du chimérisme après allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer 104:12, pages S59-S64.
Crossref
Crossref
K.V. Bogdanov, D.V. Motorin, T.S. Nikulina, O.S. Pisotskaya, D.V. Babenetskaya, Y.V. Mirolyubova, O.Y. Volkova & A.Y. Zaritskiy. (2017) Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT. Biomeditsinskaya Khimiya 63:6, pages 570-581.
Crossref
Crossref
R Duléry, O Nibourel, J Gauthier, V Elsermans, H Behal, V Coiteux, L Magro, A Renneville, A Marceau, T Boyer, B Quesnel, C Preudhomme, A Duhamel & I Yakoub-Agha. (2017) Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML. Bone Marrow Transplantation 52:4, pages 539-543.
Crossref
Crossref
Giovanni Rossi, Maria Marta Minervini, Angelo Michele Carella, Lorella Melillo & Nicola Cascavilla. 2016. Wilms Tumor. Wilms Tumor
273
285
.
M Goswami, K S McGowan, K Lu, N Jain, J Candia, N F Hensel, J Tang, K R Calvo, M Battiwalla, A J Barrett & C S Hourigan. (2015) A multigene array for measurable residual disease detection in AML patients undergoing SCT. Bone Marrow Transplantation 50:5, pages 642-651.
Crossref
Crossref
Daniel Steinbach, Peter Bader, Andre Willasch, Stephan Bartholomae, Klaus-Michael Debatin, Martin Zimmermann, Ursula Creutzig, Dirk Reinhardt & Bernd Gruhn. (2015) Prospective Validation of a New Method of Monitoring Minimal Residual Disease in Childhood Acute Myelogenous Leukemia. Clinical Cancer Research 21:6, pages 1353-1359.
Crossref
Crossref
Sophia Yohe. (2015) Molecular Genetic Markers in Acute Myeloid Leukemia. Journal of Clinical Medicine 4:3, pages 460-478.
Crossref
Crossref
Giovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, Francesco di Nardo, Chiara de Waure, Michele Mario Greco, Emanuela Merla, Giovanni Pio de Cillis, Nicola Di Renzo, Angela Melpignano, Silvana Capalbo, Gaetano Palumbo, Giovanni Pisapia & Nicola Cascavilla. (2015) Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression. Leukemia Research 39:2, pages 138-143.
Crossref
Crossref
A Israyelyan, L Goldstein, W Tsai, L Aquino, S J Forman, R Nakamura & D J Diamond. (2014) Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation. Bone Marrow Transplantation 50:1, pages 26-33.
Crossref
Crossref
Theis Helge Terwey, Philipp Georg Hemmati, Marion Nagy, Heike Pfeifer, Nicola Gökbuget, Monika Brüggemann, Tanja Melinh Le Duc, Philipp le Coutre, Bernd Dörken & Renate Arnold. (2014) Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction after Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation 20:10, pages 1522-1529.
Crossref
Crossref
Mariana Bastos-Oreiro, Ana Perez-Corral, Carolina Martínez-Laperche, Leyre Bento, Cristina Pascual, Mi Kwon, Pascual Balsalobre, Cristina Muñoz, Elena Buces, David Serrano, Jorge Gayoso, Ismael Buño, Javier Anguita & José Luís Diéz-Martín. (2014) Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation. European Journal of Haematology 93:3, pages 239-246.
Crossref
Crossref
Christopher S. Hourigan, Philip McCarthy & Marcos de Lima. (2014) Reprint of: Back to the Future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 20:2, pages S8-S17.
Crossref
Crossref
Christopher S. Hourigan, Philip McCarthy & Marcos de Lima. (2014) Back to the Future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 20:2, pages 154-163.
Crossref
Crossref